Konjenital Glikozilasyon Bozukluğu Tip II

Öz

Konjenital glikozilasyon bozuklukları ( CDG ) glikanların sentezinde ve diğer bileşiklere bağlanmasında defektlerin neden olduğu geniş bir genetik hastalıklar grubudur. İlk hastaların tanımlandığı 1980 yılından beri 40 tip CDG ( protein ve lipid glikozilasyon defektlerini kapsayan ) keşfedilmiştir. Konjenital glikozilasyon bozuklukları; esasen karaciğer-bağırsak hastalığı olan CDG-1b hariç tüm sistemleri özellikle de santral sinir sistemini etkiler.Açıklanamayan nörolojik bulguları ( psikomotor retardasyon, hipotoni, hiporefleksi, serebellar hipoplazi, konvülziyon ), hipoglisemisi, kolestazisi, karaciğer işlev bozuklukları, koagulopatisi, büyüme geriliği, görme bozuklukları ve iskelet tutulumu olan hastalarda konjenital glikozilasyon bozuklukları ayırıcı tanıda akla getirilmelidir.Burada, hipotonisi, psikomotor geriliği, büyüme geriliği, fasial dismorfisi, karaciğer tutulumu, iskelet bulguları ve hipoglisemisi olan ve izoelektrik odaklamada sialotransferrinleri tip 2 şekli gösteren kız hastamızı sunuyoruz.

Anahtar Kelimeler

• Konjenital glikozilasyon bozuklukları, tip II, infant

CONGENITAL DISORDER OF GLYCOSYLATION TYPE II

Öz

Congenital disorders of glycosylation ( CDG ) are a large group of genetic diseases resulting from defects in the synthesis of glycans and in the attachment of glycans to other compounds. Since 1980, the first description of patients, 40 types of CDG ( including protein and lipid glycolysation defects ) have been discovered. CDGs affect all systems and particularly the CNS, except for CDG -Ib, which is mainly a hepatic-intestinal disease.CDGs must be kept in mind by the pediatricians in the differential diagnosis of the patients with unexplained neurologic findings ( psychomotor retardation, hypotonia, hyporeflexia, cerebellar hypoplasia, convulsion ), hypoglycemia, cholestasis, liver function disorders, coagulopathy, failure to thrive, ocular disorders and skeletal involvement. We present an infant girl with psychomotor retardation, growth retardation, facial dysmorphy, liver involvement, skeletal findings, hypoglycemia and type 2 pattern of sialotransferrins in isoelectric focusing

Anahtar Kelimeler

• Congenital disorder of glycosylation, type II, infant

Kaynakça

1. Jaeken J, Vanderschueren-Lodeweyckx M, Casaer P, Snoeck L, Corbeel L, Eggermont E, et al. Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG deficiency, increased serum arylsulphatase A and inc- reased CSF protein: a new syndrome? Pediatr Res 1980;14:179.
2. Coşkun T. Konjenital Glikozilasyon Bozuklukları. Katkı Pediatri Dergisi 2004;25(4):1090-1120.
3. Jaeken J, Hennet T, Freeze HH, Matthijs G. On the nomenclatu- re of congenital disorders of glycosylation (CDG). J Inherit Metab Dis 2008;31(6):669-72.
4. Grunewald S, Matthijs G, Jaeken J. Congenital disorders of glycosylation: a review. Pediatr Res 2002;52(5):618-24.
5. Freeze HH, Patterson MC. Disorders of Glycosylation. In: Swaiman KF, Ashwal S, Ferriero DM (eds). Pediatric Neurology Principles & Practice ( Volume I ). Philadelphia: MOSBY Elseviere 2006:645-52.
6. Jaeken J, Matthijs G. Congenital disorders of glycosylation: a ra- pidly expanding disease family. Annu Rev Genomics Hum Genet 2007;8:261-78.
7. Marquardt T, Denecke J. Congenital disorders of glycosylation: re- view of their molecular bases, clinical presentations and specific therapies. Eur J Pediatr 2003;162(6):359-79.
8. Bruinsma P, Spelbrink RG, Nothwehr SF. Retrograde trans- port of the mannosyltransferase Och1p to the early Golgi requ- ires a component of the COG transport complex. J Biol Chem 2004;279(38):39814-23.

9. Loh E, Hong W. The binary interacting network of the con- served oligomeric Golgi tethering complex. J Biol Chem 2004;279(23):24640-8.
10. Jaeken J, Carchon H. Congenital disorders of glycosylation: a boo- ming chapter of pediatrics. Curr Opin Pediatr 2004;16(4):434-9.
11. De Praeter CM, Gerwig GJ, Bause E, Nuytinck LK, Vliegenthart JF, Breuer W, et al. A novel disorder caused by defective biosyn- thesis of N-linked oligosaccharides due to glucosidase I deficiency. Am J Hum Genet 2000;66(6):1744-56.
12. Wu X, Steet RA, Bohorov O, Bakker J, Newell J, Krieger M, et al. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat Med 2004;10(5):518-23.
13. Cansu A, Ezgü FS, Serdaroğlu A, Hırfanoğlu T, Hasanoğlu A. Hi- pereksansibilite ile presente olan bir CDG Tip II olgusu. Turkiye Klinikleri J Pediatr Sci 2005;1(10):1-2.
14. Coman D, Irving M, Kannu P, Jaeken J, Savarirayan R. The ske- letal manifestations of the congenital disorders of glycosylation. Clin Genet 2008;73(5):507-15.
15. Nsibu NC, Jaeken J, Carchon H, Mampunza M, Sturiale L, Garoz- zo D et al. Clinical and biochemical features in a Congolese infant with congenital disorder of glycosylation (CDG)-IIx. Eur J Paedi- atr Neurol 2008;12(3):257-61.
16. Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G. Carbohydrate deficient glycoprotein syndrome type II: a defici- ency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child 1994;71(2):123-7.
17. Hansske B, Thiel C, Lübke T, Hasilik M, Höning S, Peters V, et al. Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4- galactosyltransferase I causes the congenital disorder of glycosyla- tion type IId. J Clin Invest 2002;109(6):725-33.
18. Foulquier F, Vasile E, Schollen E, Callewaert N, Raemaekers T, Qu- elhas D, et al. Conserved oligomeric Golgi complex subunit 1 de- ficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. Proc Natl Acad Sci USA 2006;103(10):3764-9.
19. Foulquier F, Ungar D, Reynders E, Zeevaert R, Mills P, García- Silva MT, et al. A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation. Hum Mol Genet 2007;16(7):717-30.